Medicine
Zaynich 2 g/1 g powder for injection
Zaynich 2 g/1 g powder for injection is a prescription medicine containing Cefepime and Zidebactam for intravenous use, marketed by Wockhardt, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store ZAYNICH vials refrigerated at 2°C to 8°C (36°F to 46°F), brief…
Key facts
- Active ingredient (INN)
- Cefepime and Zidebactam
- Brand
- Zaynich
- Strength
- 2 g/1 g
- Dosage form
- Powder for injection
- Route
- Intravenous
- Packs
- 1 vial
- Marketing authorisation holder
- Wockhardt
- Manufacturer
- WockhardtIndia
- Origin register
- US FDA, United States
- Storage
- Store ZAYNICH vials refrigerated at 2°C to 8°C (36°F to 46°F), brief excursions are permitted up to 25°C (77°F). Storage after reconstitution and dilution and administration instructions are described elsewhere in the labeling.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.20Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 29 May 2026
- Identifiers
- RxCUI 2744819, 2744824DailyMed set ID c84e652e-5e76-4568-8812-bd5fa34803b6NDC 87706-866Application NDA220787
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 vial, single-dose in 1 carton / 1 injection, powder, for solution in 1 vial, single-dose | 87706-866-01 | WockhardtIndia | 29 May 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 29 May 2026 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Cefepime and Zidebactam is a fixed-dose combination medicine indicated for the treatment of adult patients with complicated urinary tract infections (cUTI) including pyelonephritis caused by designated susceptible microorganisms, among other approved uses. MedsAcross supplies Cefepime and Zidebactam for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Cefepime and ZidebactamFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- ZAYNICH prescribing information (Wockhardt) · U.S. National Library of Medicine, DailyMed
Need Zaynich 2 g/1 g powder for injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.